Lucene search

K
osvGoogleOSV:PYSEC-2023-129
HistoryJul 21, 2023 - 7:15 p.m.

PYSEC-2023-129

2023-07-2119:15:00
Google
osv.dev
8
indico
cross-site-scripting
vulnerability
update
submission privileges
event management

CVSS3

5.4

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality Impact

LOW

Integrity Impact

LOW

Availability Impact

NONE

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

EPSS

0.001

Percentile

32.7%

Indico is an open source a general-purpose, web based event management tool. There is a Cross-Site-Scripting vulnerability in confirmation prompts commonly used when deleting content from Indico. Exploitation requires someone with at least submission privileges (such as a speaker) and then someone else to attempt to delete this content. Considering that event organizers may want to delete suspicious-looking content when spotting it, there is a non-negligible risk of such an attack to succeed. The risk of this could be further increased when combined with some some social engineering pointing the victim towards this content. Users need to update to Indico 3.2.6 as soon as possible. See the docs for instructions on how to update. Users who cannot upgrade should only let trustworthy users manage categories, create events or upload materials (“submission” privileges on a contribution/event). This should already be the case in a properly-configured setup when it comes to category/event management. Note that a conference doing a Call for Abstracts actively invites external speakers (who the organizers may not know and thus cannot fully trust) to submit content, hence the need to update to a a fixed version ASAP in particular when using such workflows.

CVSS3

5.4

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality Impact

LOW

Integrity Impact

LOW

Availability Impact

NONE

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

EPSS

0.001

Percentile

32.7%

Related for OSV:PYSEC-2023-129